Preventing recurrent myocardial infarction

References

• Herrick JB. Clinical features of sudden death. JAMA 1912: 59: 2015
   Google Scholar
• Wilson FN, Johnston FD, Rosenbaum FF, et al. The precordial electrocardiogram. Am Heart J 1944: 27: 19
   Google Scholar
• Pratt CM, Roberts R. Non-Q-wave myocardial infarction: recognition, pathogenesis, prognosis and management. Baylor Cardiol Series 1985: 8(5)
   Google Scholar
• Roberts R, Gowda KS, Ludbrook PA, et al. Specificity of elevated serum MB creatine Phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol 1975: 36(4): 433–7
   PubMed Web of Science ®Google Scholar
• Grande P. Christiansen C, Pedersen A, et al. Optimal diagnosis in acute myocardial infarction: a cost-effectiveness study. Circulation 1980: 61 (4): 723–8
   PubMed Web of Science ®Google Scholar
• Marmor A, Sobel BE, Roberts R. Factors presaging early recurrent myocardial infarction (“extension”). Am J Cardiol 1981: 48(4): 603–10
   PubMed Web of Science ®Google Scholar
• Marmor A, Geltman EM, Schechtman K, et al. Recurrent myocardial infarction: clinical predictors and prognostic implications. Circulation 1982: 66(2): 415–21
   PubMed Web of Science ®Google Scholar
• Hutter AM Jr, DeSanctis RW, Flynn T, et al. Nontransmural myocardial infarction: a comparison of hospital and late clinical course of patients with that of matched patients with transmural anterior and transmural inferior myocardial infarction. Am J Cardiol 1981: 48(4): 595–602
   PubMed Web of Science ®Google Scholar
• Roberts R. Nontransmural myocardial infarction. Newsletter, Council on Clinical Cardiology. American Heart Association 1985: 11(1): 1–17: publication No. SC-85-CLC
   Google Scholar
• Beta-Blocker Heart Attack Trial Research Group. Randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982: 247(12): 1707–14
   PubMed Web of Science ®Google Scholar
• Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981: 304(14): 801–7
   PubMed Web of Science ®Google Scholar
• Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction: results of a double-blind, randomized. multicenter trial. N Engl J Med 1986: 315(7): 423–9
   PubMed Web of Science ®Google Scholar
• Gibson RS, Young PM, Boden WE, et al. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q-wave myocardial infarction: results from the multicenter Diltiazem Reinfarction Study. Am J Cardiol 1987: 60(4): 203–9
   PubMed Web of Science ®Google Scholar
• Roberts R. Recognition, diagnosis, and prognosis of early reinfarction: the role of calcium-channel blockers. Circulation 1987: 75(6 Pt 2): 139–47
   PubMed Web of Science ®Google Scholar
• Verapamil and acute myocardial infarction: the Danish Study Group on verapamil in myocardial infarction. Eur Heart J 1984: 5(7): 516–28
   PubMed Web of Science ®Google Scholar
• Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation 1984: 69(4): 740–7
   PubMed Web of Science ®Google Scholar
• Wilcox RG, Hampton JR, Banks DC, et al. Trial of early nifedipine treatment in patients with suspected myocardial infarction (the TRENT study). Br Heart J 1986: 55: 506
   Google Scholar
• Neufeld HN. Calcium antagonists in secondary prevention after actue myocardial infarction: the Secondary Prevention Reinfarction Nifedipine Trial (SPRINT). Eur Heart J 1986: 7(Suppl B): 51–2
   PubMedGoogle Scholar
• Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Br Hear J 1986: 56(5): 400–13
   PubMedGoogle Scholar
• Walker L, MacKenzie G, Adgey J. Effect of nifedipine in the early phase of acute myocardial infarction on enzymatically estimated infarct size and arrhythmias. Br Heart J 1987: 57: 83–4
   Google Scholar
• Branagan JP, Walsh K, Kelley P. et al. Effect of early treatment with nifedipine in suspected acute myocardial infarction. Eur Heart J 1986: 7(10): 859–65
   PubMed Web of Science ®Google Scholar
• Bush LR. Buja LM, Tilton G, et al. Effects of propranolol and diltiazem alone and in combination on the recovery of left ventricular segmental function after temporary coronary occlusion and long-term reperfusion in conscious dogs. Circulation 1985: 72(2): 413–30
   PubMed Web of Science ®Google Scholar
• Knabb RM, Rosamond RL, Fox KA, et al. Enhancement of salvage of reperfused ischemic myocardium by diltiazem. J Am Coll Cardiol 1986: 8(4): 861–71
   PubMed Web of Science ®Google Scholar
• Marmor A, Ludbrook PA, Sobel BE, et al. Vascular determinants of early recurrent myocardial infarction. (Abstr) Am J Cardiol 1981: 47: 418
   Web of Science ®Google Scholar
• DeWood MA, stifter WF, Simpson CS. et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 1986: 315(7): 417–23
   PubMed Web of Science ®Google Scholar
• Gibson RS, Beller G A, Gheorghiade M, et al. The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q-wave infarction: a prospective natural history study. Circulation 1986: 73(6): 1186–98
   PubMed Web of Science ®Google Scholar